Adverse Effects Post COVID-19 Vaccination and its Association with Age, Gender and Comorbid Disease in Basrah City Southern of Iraq.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY

Current drug safety Pub Date : 2024-01-01 DOI:10.2174/1574886318666230525142152

Zainab Najim Abdul-Nabi, Noor Kadhim Mohamed-Jawad, Noor Yousif Fareed, Nadheerah Falih Neamah, Falah Hassan Shari

{"title":"Adverse Effects Post COVID-19 Vaccination and its Association with Age, Gender and Comorbid Disease in Basrah City Southern of Iraq.","authors":"Zainab Najim Abdul-Nabi, Noor Kadhim Mohamed-Jawad, Noor Yousif Fareed, Nadheerah Falih Neamah, Falah Hassan Shari","doi":"10.2174/1574886318666230525142152","DOIUrl":null,"url":null,"abstract":"Background: Vaccination against COVID-19 virus is the most valuable tool available for protection during the pandemic of coronavirus. The clinical manifestation post-vaccination is a barrier to vaccination for many people in Iraq and worldwide.Objectives: The objective of this study is identifying various clinical manifestations occurring after receiving vaccines among individuals in Basrah Governorate. Moreover, we examine its association with respondents' demographics and the type of vaccine they received.Methods: A cross-section study was conducted in Basrah, southern Iraq. Research data were collected through an online questionnaire. The data were analyzed using both descriptive and analytic statistical tools using the SPSS program.Results: Most of the participants (86.68%) received the vaccine. The side effects were reported in 71.61% of vaccinated individuals. Fever and muscle pain were the two most experienced clinical manifestations, while lymph node enlargement and disturbances in taste and/or smell sensations were reported infrequently. Adverse effects were mostly reported with the Pfizer BioNTech vaccine receiver. Females and those in the younger age group also reported a significantly higher incidence of side effects.Conclusion: Most adverse effects related to the COVID-19 vaccine were minor and could be tolerated without the need for hospital admission.","PeriodicalId":10777,"journal":{"name":"Current drug safety","volume":" ","pages":"248-254"},"PeriodicalIF":1.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574886318666230525142152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Vaccination against COVID-19 virus is the most valuable tool available for protection during the pandemic of coronavirus. The clinical manifestation post-vaccination is a barrier to vaccination for many people in Iraq and worldwide.

Objectives: The objective of this study is identifying various clinical manifestations occurring after receiving vaccines among individuals in Basrah Governorate. Moreover, we examine its association with respondents' demographics and the type of vaccine they received.

Methods: A cross-section study was conducted in Basrah, southern Iraq. Research data were collected through an online questionnaire. The data were analyzed using both descriptive and analytic statistical tools using the SPSS program.

Results: Most of the participants (86.68%) received the vaccine. The side effects were reported in 71.61% of vaccinated individuals. Fever and muscle pain were the two most experienced clinical manifestations, while lymph node enlargement and disturbances in taste and/or smell sensations were reported infrequently. Adverse effects were mostly reported with the Pfizer BioNTech vaccine receiver. Females and those in the younger age group also reported a significantly higher incidence of side effects.

Conclusion: Most adverse effects related to the COVID-19 vaccine were minor and could be tolerated without the need for hospital admission.

查看原文本刊更多论文

伊拉克南部巴士拉市接种 COVID-19 疫苗后的不良反应及其与年龄、性别和合并疾病的关系。

背景：接种 COVID-19 病毒疫苗是在冠状病毒大流行期间提供保护的最有价值的工具。接种疫苗后的临床表现是伊拉克和全世界许多人接种疫苗的障碍：本研究旨在确定巴士拉省个人接种疫苗后出现的各种临床表现。此外，我们还研究了临床表现与受访者的人口统计学特征和接种疫苗类型之间的关系：方法：在伊拉克南部巴士拉进行了一项横断面研究。研究数据通过在线问卷收集。使用 SPSS 程序的描述性和分析性统计工具对数据进行了分析：大多数参与者（86.68%）接种了疫苗。71.61%的接种者报告了副作用。发热和肌肉疼痛是两种最常见的临床表现，而淋巴结肿大和味觉和/或嗅觉障碍则很少见。不良反应主要发生在辉瑞生物技术公司的疫苗接种者身上。女性和年轻群体的副作用发生率也明显较高：结论：与 COVID-19 疫苗相关的大多数不良反应都很轻微，可以耐受，无需入院治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current drug safety PHARMACOLOGY & PHARMACY-

CiteScore

2.10

自引率

0.00%

发文量

112

期刊介绍： Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.